vs
Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and BWX Technologies, Inc. (BWXT). Click either name above to swap in a different company.
Ardent Health, Inc. is the larger business by last-quarter revenue ($1.6B vs $885.8M, roughly 1.8× BWX Technologies, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs 2.8%, a 7.7% gap on every dollar of revenue.
Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.
BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.
ARDT vs BWXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $885.8M |
| Net Profit | $45.0M | $93.0M |
| Gross Margin | — | — |
| Operating Margin | 5.8% | 10.4% |
| Net Margin | 2.8% | 10.5% |
| Revenue YoY | — | 18.7% |
| Net Profit YoY | — | 30.9% |
| EPS (diluted) | $0.32 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | $885.8M | ||
| Q3 25 | $1.6B | $866.3M | ||
| Q2 25 | $1.6B | $764.0M | ||
| Q1 25 | $1.5B | $682.3M | ||
| Q4 24 | — | $746.3M | ||
| Q3 24 | $1.4B | $672.0M | ||
| Q2 24 | $1.5B | $681.5M | ||
| Q1 24 | — | $604.0M |
| Q4 25 | $45.0M | $93.0M | ||
| Q3 25 | $-23.5M | $82.1M | ||
| Q2 25 | $73.0M | $78.4M | ||
| Q1 25 | $41.4M | $75.5M | ||
| Q4 24 | — | $71.0M | ||
| Q3 24 | $26.3M | $69.5M | ||
| Q2 24 | $42.8M | $73.0M | ||
| Q1 24 | — | $68.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 25.1% | ||
| Q1 25 | — | 24.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.4% | ||
| Q2 24 | — | 24.7% | ||
| Q1 24 | — | 24.6% |
| Q4 25 | 5.8% | 10.4% | ||
| Q3 25 | -0.1% | 13.1% | ||
| Q2 25 | 7.4% | 13.4% | ||
| Q1 25 | 5.0% | 14.2% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | 3.9% | 14.4% | ||
| Q2 24 | 5.6% | 14.5% | ||
| Q1 24 | — | 15.4% |
| Q4 25 | 2.8% | 10.5% | ||
| Q3 25 | -1.5% | 9.5% | ||
| Q2 25 | 4.4% | 10.3% | ||
| Q1 25 | 2.8% | 11.1% | ||
| Q4 24 | — | 9.5% | ||
| Q3 24 | 1.8% | 10.3% | ||
| Q2 24 | 2.9% | 10.7% | ||
| Q1 24 | — | 11.3% |
| Q4 25 | $0.32 | $1.02 | ||
| Q3 25 | $-0.17 | $0.89 | ||
| Q2 25 | $0.52 | $0.85 | ||
| Q1 25 | $0.29 | $0.82 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | $0.19 | $0.76 | ||
| Q2 24 | $0.34 | $0.79 | ||
| Q1 24 | — | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $709.6M | $499.8M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $1.3B | $1.2B |
| Total Assets | $5.3B | $4.3B |
| Debt / EquityLower = less leverage | 0.84× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $709.6M | $499.8M | ||
| Q3 25 | $609.4M | $79.6M | ||
| Q2 25 | $540.6M | $37.0M | ||
| Q1 25 | $495.0M | $55.4M | ||
| Q4 24 | — | $74.1M | ||
| Q3 24 | $563.1M | $35.5M | ||
| Q2 24 | $334.5M | $48.3M | ||
| Q1 24 | — | $45.9M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $739.9M | $998.5M | ||
| Q1 24 | — | $946.2M |
| Q4 25 | $5.3B | $4.3B | ||
| Q3 25 | $5.2B | $3.8B | ||
| Q2 25 | $5.0B | $3.7B | ||
| Q1 25 | $4.9B | $3.1B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | $4.8B | $2.9B | ||
| Q2 24 | $4.6B | $2.8B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | 0.84× | — | ||
| Q3 25 | 0.88× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.93× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $223.4M | $127.0M |
| Free Cash FlowOCF − Capex | — | $56.8M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 7.9% |
| Cash ConversionOCF / Net Profit | 4.97× | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | — | $295.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $223.4M | $127.0M | ||
| Q3 25 | $154.4M | $143.2M | ||
| Q2 25 | $117.5M | $159.0M | ||
| Q1 25 | $-24.8M | $50.6M | ||
| Q4 24 | — | $276.9M | ||
| Q3 24 | $89.7M | $32.6M | ||
| Q2 24 | — | $65.9M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | — | $56.8M | ||
| Q3 25 | — | $94.9M | ||
| Q2 25 | — | $126.3M | ||
| Q1 25 | — | $17.3M | ||
| Q4 24 | — | $224.4M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $35.5M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | — | 6.4% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | — | -1.1% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | — | 7.9% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | 4.97× | 1.37× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | 1.61× | 2.03× | ||
| Q1 25 | -0.60× | 0.67× | ||
| Q4 24 | — | 3.90× | ||
| Q3 24 | 3.41× | 0.47× | ||
| Q2 24 | — | 0.90× | ||
| Q1 24 | — | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARDT
Segment breakdown not available.
BWXT
| Nuclear Component Program | $436.4M | 49% |
| Nuclear Manufacturing | $134.8M | 15% |
| Cost Plus Fee | $116.1M | 13% |
| Uranium And Nuclear Services | $103.8M | 12% |
| Commercial Operations | $49.0M | 6% |
| Commercial Operations Segment | $33.7M | 4% |
| Transferred At Point In Time | $1.3M | 0% |
